相关实验视频

Updated: Mar 6, 2026

Ameliorating Osteoarthritis in Mice Using Silver Nanoparticles

Ameliorating Osteoarthritis in Mice Using Silver Nanoparticles

Published on: June 2, 2023

基于纳米载体的黄素的向输送:非传染性关节炎的潜在治疗策略

Baihui Cai^1,2, Yiting Cai^1,3,4, Han Wang^1,2

¹Department of Orthopedics, Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, 330006, China.

Inflammopharmacology

|March 5, 2026

概括

纳米载体增强了关节炎治疗的黄素输送,提高了其有效性和生物可用性. 这种方法对管理诸如类风湿性关节炎等炎症性关节疾病有希望.

科学领域:

药理学药理学是指药理学的学科.
生物技术是生物技术.
类风湿病学类风湿病学

背景情况:

关节炎会导致关节损伤和疼痛,目前的治疗方法缺乏特异性.
黄素具有抗炎功效,但具有较差的溶解性和生物利用性.
纳米载体系统为克服黄素的局限性提供了一个潜在的解决方案.

研究的目的:

为了研究基于纳米载体的黄素在非传染性关节炎中的疗效.
审查不同的纳米载体类型,以针对性地提供黄素.
评估纳米载体对黄素的药理动力学特性和治疗结果的影响.

主要方法:

对脂质体,基于生物分子的纳米颗粒,纳米乳液和改善的纳米载体进行库尔库输送的审查.
分析纳米载体对黄素的药理动力学,循环时间和稳定性的影响.
在各种非传染性关节炎模型中对纳米载体-黄素系统的评估.

主要成果:

纳米载体显著提高了黄素的生物可用性和治疗疗效.
增强的药理动力学和延长的循环减少了黄素的降解.
在治疗结性脊髓炎,类风湿性关节炎,青少年异常性关节炎和痛风方面表现出潜力.

结论:

基于纳米载体的黄素输送对于非传染性关节炎是有效的.
这些系统减少炎症,调节免疫反应,缓解疾病症状.
建议对纳米载体优化和临床试验进行进一步的研究.

关键词:

库尔库明是一种黄素.纳米载体的使用方法非传染性关节炎是一种非传染性关节炎.骨关节炎是一种骨关节炎.类风湿性关节炎类风湿性关节炎类风湿性关节炎

更多相关视频

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier

Published on: April 26, 2016

Polyethyleneimine-coated Iron Oxide Nanoparticles as a Vehicle for the Delivery of Small Interfering RNA to Macrophages In Vitro and In Vivo

Polyethyleneimine-coated Iron Oxide Nanoparticles as a Vehicle for the Delivery of Small Interfering RNA to Macrophages In Vitro and In Vivo

Published on: February 5, 2019

相关概念视频

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...

Modified-Release Drug Delivery Systems: Site-Targeted

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.